Emcure Pharma’s Ahmedabad facility clears US FDA inspection without observations

The US drug regulator has completed a pre-approval inspection at Emcure’s Ahmedabad oncology facility without issuing a Form 483.

Leave a Reply

Your email address will not be published. Required fields are marked *